Immunohistochemically, ALK+ DLBCL does not express B-lineage markers (CD20 and CD79α), T-lineage markers (CD3), cytotoxic granular proteins (granzyme B and TIA-1) or CD30. This evidence concerns the gene TNFRSF8 and diffuse large B-cell lymphoma.